BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,178,000 | -85.1% | 40,000 | -88.6% | 0.42% | -88.8% |
| Q3 2019 | $14,602,000 | +233.5% | 350,000 | +250.0% | 3.72% | +309.7% |
| Q2 2019 | $4,379,000 | -51.4% | 100,000 | -42.9% | 0.91% | -61.4% |
| Q1 2019 | $9,007,000 | -11.4% | 175,000 | -36.4% | 2.35% | -36.3% |
| Q4 2018 | $10,170,000 | +35.4% | 275,000 | +37.5% | 3.69% | +131.3% |
| Q3 2018 | $7,510,000 | +6055.7% | 200,000 | +9900.0% | 1.60% | +4333.3% |
| Q2 2018 | $122,000 | -99.2% | 2,000 | -99.7% | 0.04% | -98.9% |
| Q1 2018 | $16,103,000 | +222.6% | 625,100 | +237.9% | 3.26% | +178.4% |
| Q4 2017 | $4,991,000 | – | 185,000 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |